SEC Comment Letter for ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858) (ACHV) — Apr 2, 2020

ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858)
Date: April 2, 2020 · CIK: 0000949858 · Accession: 0000000000-20-002880

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

April 2, 2020

Author

Richard Stewart

Form

UPLOAD

Company

ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858)

Letter

April 2, 2020 Richard Stewart Chief Executive Officer Achieve Life Sciences, Inc. 1040 West Georgia, Suite 1030 Vancouver, British Columbia, V6E 4H1 Re:Achieve Life Sciences, Inc. Preliminary Proxy Statement on Schedule 14A Filed March 30, 2020 File No. 033-80623 Dear Mr. Stewart: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Chelsea Anderson, Esq.

Show Raw Text

April 2, 2020
Richard Stewart
Chief Executive Officer
Achieve Life Sciences, Inc.
1040 West Georgia, Suite 1030
Vancouver, British Columbia, V6E 4H1
Re:Achieve Life Sciences, Inc.
Preliminary Proxy Statement on Schedule 14A
Filed March 30, 2020
File No. 033-80623
Dear Mr. Stewart:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Chelsea Anderson, Esq.

SecProbe.io